首页 正文

Therapeutic Effects of PCSK9 Inhibitors on Lp(a)-Associated Atherosclerosis: Evidence and Perspectives

{{output}}
Lipoprotein(a) [Lp(a)] is a genetically determined independent risk factor for atherosclerotic cardiovascular disease (ASCVD) that drives a significant residual risk through pro-atherogenic, pro-inflammatory, and prothrombotic pathways. However, current mainst... ...